Graftys Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Employees
-
16
- Latest Deal Type
-
M&A
Graftys General Information
Description
Developer of synthetic bone biomaterials designed to be used for reconstructive orthopedic surgery. The company offers a range of innovative, safe, and fully injectable calcium phosphate bone graft substitutes designed to target specific clinical applications, enabling patients to get standard products for bone reconstructive and trauma surgery.
Contact Information
Website
www.graftys.comCorporate Office
- 415 Rue Claude Nicolas ledoux
- Cedex 3
- 13854 Aix En Provence
- France
Corporate Office
- 415 Rue Claude Nicolas ledoux
- Cedex 3
- 13854 Aix En Provence
- France
Graftys Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 01-Jun-2024 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 01-Jul-2022 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 01-Feb-2019 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 26-Apr-2011 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 08-Nov-2010 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 29-May-2009 | Completed | Startup | |||
| 3. Early Stage VC | 03-Jun-2008 | Completed | Startup | |||
| 2. Early Stage VC | 16-Mar-2007 | $1.98M | $1.98M | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Graftys Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Preference | ||||||||
| Preference | ||||||||
| Preference | 74,801 | $1.395599 | $10.47 | $10.47 | 1x | $10.47 | 2.68% | |
| Preference | 239,822 | $1.395599 | $8.73 | $8.73 | 1x | $8.73 | 8.59% |
Graftys Comparisons
Industry
Financing
Details
Graftys Competitors (24)
One of Graftys’s 24 competitors is CoreBone, a Venture Capital-Backed company based in Misgav, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CoreBone | Venture Capital-Backed | Misgav, Israel | ||||
| Spine Wave | Venture Capital-Backed | Shelton, CT | ||||
| Bonalive Biomaterials | Corporation | Turku, Finland | ||||
| DePuy Synthes | Corporate Backed or Acquired | Warsaw, IN | ||||
| Graham Medical Technologies | Corporate Backed or Acquired | Macomb, MI |
Graftys Patents
Graftys Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3999136-A1 | Bone cement with hyaluronic acid | Inactive | 19-Jul-2019 | ||
| US-20220273841-A1 | Bone cement with hyaluronic acid | Inactive | 19-Jul-2019 | ||
| WO-2021013748-A1 | Bone cement with hyaluronic acid | Inactive | 19-Jul-2019 | ||
| CA-3058931-A1 | Phosphocalcic cement composition comprising blood | Pending | 06-Apr-2016 | ||
| EP-3228334-A1 | Phosphocalcic cement composition comprising blood | Inactive | 06-Apr-2016 | A61L24/12 |
Graftys Signals
Graftys Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Financière Mirabel | Corporation | Minority | ||
| GO Capital | Venture Capital | Minority | ||
| Incubateur Impulse | Accelerator/Incubator | Minority | ||
| La Financiere viveris | PE/Buyout | Minority | ||
| Noshaq | Venture Capital | Minority |
Graftys Acquisitions (2)
Graftys’s most recent deal was a Merger/Acquisition with Biologics for life. The deal was made on 15-Nov-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Biologics for life | 15-Nov-2021 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Biologics 4 Life | 08-Nov-2021 | Merger/Acquisition | Biotechnology |
Graftys FAQs
-
When was Graftys founded?
Graftys was founded in 2005.
-
Where is Graftys headquartered?
Graftys is headquartered in Aix En Provence, France.
-
What is the size of Graftys?
Graftys has 16 total employees.
-
What industry is Graftys in?
Graftys’s primary industry is Surgical Devices.
-
Is Graftys a private or public company?
Graftys is a Private company.
-
What is Graftys’s current revenue?
The current revenue for Graftys is .
-
How much funding has Graftys raised over time?
Graftys has raised $20.3M.
-
Who are Graftys’s investors?
Financière Mirabel, GO Capital, Incubateur Impulse, La Financiere viveris, and Noshaq are 5 of 11 investors who have invested in Graftys.
-
Who are Graftys’s competitors?
CoreBone, Spine Wave, Bonalive Biomaterials, DePuy Synthes, and Graham Medical Technologies are some of the 24 competitors of Graftys.
-
When was Graftys acquired?
Graftys was acquired on 01-Jun-2024.
-
Who acquired Graftys?
Graftys was acquired by Noraker (Therapeutic Devices).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process